Awards & Advancement

Regeneron names LaRosa senior VP

Tuesday, September 6, 2011 12:44 PM

Regeneron Pharmaceuticals has named Joseph J. LaRosa senior vice president, general counsel and secretary. LaRosa will be responsible for overseeing all legal affairs, including general corporate legal matters, intellectual property and corporate compliance, and will report to Leonard S. Schleifer, M.D., Ph.D., president and chief executive officer.

More... »

SpringFire Laboratory names scientific director

Friday, September 2, 2011 11:00 AM

SpringFire Laboratory Network has named Gregory Stelzer, Ph.D., scientific director. Stelzer’s responsibilities include development and implementation of corporate and scientific strategies in addition to management of the scientific team.

More... »

Rhenovia’s RHETOX project receives EUR 1.15 million in financing

Thursday, September 1, 2011 11:06 AM

Rhenovia Pharma has been selected by the French Armaments Directorate (DGA) and the General Directorate for Competitiveness, Industry and Services of the French Ministry of Economy, Finance and Industry (DGCIS) for inclusion in the RAPID program (Support Regime for Dual Innovation in SMEs). By this distinction, Rhenovia will lead a research program, named RHETOX, which will be conducted in partnership with the French Army’s Biomedical Research Institute (IRBA). Rhenovia will receive EUR 850,000 from a global funding amount of EUR 1.15 million.

More... »

Metabolon raises $13 million in Series D financing

Wednesday, August 31, 2011 12:37 PM

Metabolon has secured $13.1 million in a Series D financing. New investor Keating Capital, joins existing investors including Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght and Fulcrum Financial Partners in the round.

More... »

ImmunoCellular names Kim to board of directors

Tuesday, August 30, 2011 11:52 AM

ImmunoCellular Therapeutics has named Helen Kim to its board of directors. She has also been elected as chairperson of the company’s product strategic committee. Kim currently serves on the board of directors at Sunesis Pharmaceuticals and as the chief business officer of NGM Biopharmaceuticals.

More... »

Yourway Transport names president, BioPharma Services

Monday, August 29, 2011 01:20 PM

Yourway Transport has named Tim Brewer president of its newly launched BioPharma Services division. Brewer will assume leadership of the company business and operations in the area of pharmaceutical and biologics services.

More... »

DVS Sciences raises $14 million, largest round in Canada life sciences, to expand CyTOF sales

Monday, August 29, 2011 08:00 AM

DVS Sciences, which invented and manufactures an instrument enabling biomarker analysis for scientific research, clinical trials and personalized medicine, has raised $14.6 million in series A financing. This is the largest venture-backed series A equity raised in Canada’s life sciences and medical technology fields in recent years, and is almost twice the average series A funding in the U.S., the company said.

More... »

Anadys names Posner to its board of directors

Tuesday, August 23, 2011 01:19 PM

Anadys Pharmaceuticals has named Brian S. Posner to its board of directors. Posner is currently a private investor and the president and founder of Point Rider Group.

More... »

Choo joins Menicon

Tuesday, August 23, 2011 12:06 PM

Menicon has named Dr. Jennifer Choo manager of specialty lens clinical affairs for Menicon Holdings B.V. Choo will oversee the company's Rose K business while also handling professional and clinical affairs for the company's growing specialty lens portfolio.

More... »

Voalté names Anderson chief nursing officer

Tuesday, August 23, 2011 11:24 AM

Voalté has named Teresa Anderson chief nursing officer. Anderson will oversee the alignment of best nursing practices and principles with Voalté’s corporate objectives.

More... »